A 90-year-old woman with moderate hypertension and a left pheochromocytoma was referred to our hospital for reassessment of the pheochromocytoma. She had a history of lung cancer and no family history of endocrine tumors. She had been diagnosed with a pheochromocytoma 15 years earlier and had declined surgical treatment decidedly since then. The adrenal tumor had enlarged, as shown on serial computed tomography (CT) images, and presently measured 64 mm in diameter (Fig. 1). She was asymptomatic until recently, and received oral doxazosin mesilate and other antihypertensive drugs.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.